BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 8402660)

  • 41. Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells.
    Yount GL; Haas-Kogan DA; Vidair CA; Haas M; Dewey WC; Israel MA
    Cancer Res; 1996 Feb; 56(3):500-6. PubMed ID: 8564961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity.
    Warenius HM; Jones M; Gorman T; McLeish R; Seabra L; Barraclough R; Rudland P
    Br J Cancer; 2000 Oct; 83(8):1084-95. PubMed ID: 10993658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of p53 overexpression on radiation sensitivity of human colon cancer cells.
    Zellars RC; Naida JD; Davis MA; Lawrence TS
    Radiat Oncol Investig; 1997; 5(2):43-9. PubMed ID: 9303056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.
    Kusumoto M; Ogawa T; Mizumoto K; Ueno H; Niiyama H; Sato N; Nakamura M; Tanaka M
    Clin Cancer Res; 1999 Aug; 5(8):2140-7. PubMed ID: 10473098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biology of marrow stromal cell lines derived from long-term bone marrow cultures of Trp53-deficient mice.
    Epperly MW; Bray JA; Carlos TM; Prochownik E; Greenberger JS
    Radiat Res; 1999 Jul; 152(1):29-40. PubMed ID: 10381838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Functional restoration of tumor suppressor p53 alters susceptibility of glioblastoma cells to irradiation--analysis using a cell line containing a temperature-sensitive mutant].
    Tsuchiya K
    Hokkaido Igaku Zasshi; 2000 Jul; 75(4):265-74. PubMed ID: 10976406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P53-independent apoptosis: a mechanism of radiation-induced cell death of glioblastoma cells.
    Haas-Kogan DA; Dazin P; Hu L; Deen DF; Israel A
    Cancer J Sci Am; 1996; 2(2):114-21. PubMed ID: 9166509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
    Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
    Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antisense oligonucleotide targeting p53 increased apoptosis of MCF-7 cells induced by ionizing radiation.
    Dai LC; Wang X; Yao X; Min LS; Qian FC; He JF
    Acta Pharmacol Sin; 2006 Nov; 27(11):1453-8. PubMed ID: 17049121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
    Fan S; Smith ML; Rivet DJ; Duba D; Zhan Q; Kohn KW; Fornace AJ; O'Connor PM
    Cancer Res; 1995 Apr; 55(8):1649-54. PubMed ID: 7712469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hydrocarbon carcinogens evade cellular defense mechanism of G1 arrest in nontransformed and malignant lung cell lines.
    Khan QA; Anderson LM
    Toxicol Appl Pharmacol; 2001 Jun; 173(2):105-13. PubMed ID: 11384212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of retinoblastoma gene product in p53-mediated DNA damage response.
    Smith ML; Zhan Q; Bae I; Fornace AJ
    Exp Cell Res; 1994 Dec; 215(2):386-9. PubMed ID: 7982477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.
    Brachman DG; Beckett M; Graves D; Haraf D; Vokes E; Weichselbaum RR
    Cancer Res; 1993 Aug; 53(16):3667-9. PubMed ID: 8339273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. G2/M-phase arrest and release in ataxia telangiectasia and normal cells after exposure to ionizing radiation.
    Hong JH; Gatti RA; Huo YK; Chiang CS; McBride WH
    Radiat Res; 1994 Oct; 140(1):17-23. PubMed ID: 7938450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ionizing radiation and cell cycle progression in ataxia telangiectasia.
    Beamish H; Khanna KK; Lavin MF
    Radiat Res; 1994 Apr; 138(1 Suppl):S130-3. PubMed ID: 8146316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Marker genes for cytotoxic exposure: p53.
    Montenarh M
    Stem Cells; 1995 May; 13 Suppl 1():136-41. PubMed ID: 7488939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p53 status, cellular recovery and cell cycle arrest as prognosticators of in vitro radiosensitivity in human pancreatic adenocarcinoma cell lines.
    Ng CE; Banerjee SK; Pavliv M; Wang G; Raaphorst GP; Aubin RA
    Int J Radiat Biol; 1999 Nov; 75(11):1365-76. PubMed ID: 10597911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240.
    Wiman KG; Magnusson KP; Ramqvist T; Klein G
    Oncogene; 1991 Sep; 6(9):1633-9. PubMed ID: 1923530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells.
    Russell KJ; Wiens LW; Demers GW; Galloway DA; Plon SE; Groudine M
    Cancer Res; 1995 Apr; 55(8):1639-42. PubMed ID: 7712467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.